The institute's scientific advisory board

To ensure that the high quality of their scientific research is maintained in the long-term, all Max Planck Institutes are regularly assessed by independent scientific advisers. The fact that the majority of those chosen are from abroad is no coincidence: advisers are international experts of the evaluated subject.

The Max Planck Institute of Neurobiology's scientific advisory board is composed of the following scientists:

• Prof. Dr. Cori Bargmann
  Howard Hughes Medical Institute (HHMI), Rockefeller University, New York, USA

• Prof. Dr. Adriano Fontana
  Clinical Immunology, University Clinic Zurich, Zurich, Switzerland

• Prof. Dr. Joan M. Goverman
  Department of Immunology, University of Washington, Seattle, USA

• Prof. Dr. Christine Holt
  Department of Physiology, Development & Neuroscience, University of Cambridge, Cambridge, United Kingdom

• Prof. Dr. Carol A. Mason
  Department of Pathology, Columbia University, New York, USA

• Prof. Dr. Markus Meister
  Department of Molecular and Cellular Biology, Harvard University, Cambridge, USA

• Prof. Dr. Louis Reichardt
  Howard Hughes Medical Institute (HHMI), University of California, San Francisco, USA

• Prof. Dr. Joshua R. Sanes
  Center for Brain Science, Harvard University, Cambridge, USA

• Prof. Dr. Michael N. Schadlen
  Department of Physiology and Biophysics, University of Washington, Seattle, USA

• Prof. Dr. Stephen W. Wilson
  Department of Cell and Developmental Biology, University College London, London, UK

• Prof. Dr. Lawrence S. Zipursky
  Howard Hughes Medical Institute (HHMI), University of California L.A., Los Angeles, USA